; and (B) by striking or the 7-year period described in section 527, and inserting the 7-year period described in section 527, or, in the case of an antifungal biological product, the 12-year period under section 351(k) of the Public Health Service Act, ; (2) in subsection (c)— (A) in paragraph (1), by inserting or, in the case of an antifungal biological product, section 351(a) of the Public Health Service Act after 505(b) ; and (B) in paragraph (2), by inserting or, in the case of an antifungal biological product, section 351 of the Public Health Service Act after 505 ; (3) in subsection (d)(1) by inserting or, in the case of an antifungal biological product, section 351(a) of the Public Health Service Act after 505(b) ; and (4) in subsection (g), in the matter preceding paragraph (1)— (A) by inserting (including antifungal biological products) after antifungal drug